Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 701–800 of 1,003
Luddy, K. A., Robertson‐Tessi, M., Tafreshi, N. K., Soliman, H. H., & Morse, D. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00429 · Cited by 46
Schneider, T. L., & Krüger, B. E. (2025) · Archive of International Journal of Cancer and Allied Science · doi:10.51847/b9vfcweavg · Cited by 42
Shi, M., Beauchamp, R. D., & Zhang, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041292 · Cited by 42
“Nevertheless, the fact remains that gene signatures determined by supervised data analysis are strongly influenced by the subset of patients used for gene selection, and the membership of a gene in such a signature is not indicative of the importance of that gene in cancer pathology [19].”
Goel, P. N., & Gude, R. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0929-8 · Cited by 48
“It starts off as a local disease but eventually metastasise to lymph nodes and distant organs, such as lung, liver and bones [3, 27].”
Indirubin Derivative 6BIO Suppresses Metastasis
Braig, S., Kressirer, C. A., Liebl, J., Bischoff, F., Zahler, S., Meijer, L., & Vollmar, A. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4358 · Cited by 42
Song, S. E., Shin, S. U., Moon, H., Ryu, H. S., Kim, K., & Moon, W. K. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4143-6 · Cited by 42
Cheng, J., Ćuk, K., Heil, J., Golatta, M., Schott, S., Sohn, C., Schneeweiß, A., Burwinkel, B., & Surowy, H. (2017) · Oncotarget · doi:10.18632/oncotarget.17384 · Cited by 44
The Extracellular Matrix and Vesicles Modulate the Breast Tumor Microenvironment
Yang, J., Bahçecioğlu, G., & Zorlutuna, P. (2020) · Bioengineering · doi:10.3390/bioengineering7040124 · Cited by 47
TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer
Cordier, C., Prevarskaya, N. B., & Lehen’kyi, V. (2021) · Cancers · doi:10.3390/cancers13246322 · Cited by 43
Sp, N., Darvin, P., Yoo, Y. B., Joung, Y. H., Kang, D. Y., Kim, D. N., Hwang, T. S., Kim, S. Y., Kim, W. S., Lee, H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1445-0 · Cited by 42
Zhang, L., Wang, G., Wang, L., Song, C., Leng, Y., Wang, X., & Kang, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1085-x · Cited by 42
Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer
Subramaniam, V., Chakrabarti, R., Prud’homme, G. J., & Jothy, S. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328334992c · Cited by 45
Holland, P. M., Miller, R. E., Jones, J. C., Douangpanya, H., Piasecki, J., Roudier, M. P., & Dougall, W. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.7.11266 · Cited by 43
Bértolo, C., Guerrero, D., Vicente, F., Córdoba, A., Esteller, M., Ropero, S., Guillén‐Grima, F., Martínez-Peñuela, J. M., & Lera, J. M. (2008) · American Journal of Clinical Pathology · doi:10.1309/j3qv9763dypv338d · Cited by 41
Chandrasekaran, S., Geng, Y., DeLouise, L. A., & King, M. R. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.052 · Cited by 41
“This is termed clonal dominance and is often reported as an accepted model of breast cancer metastasis [43].”
Brain metastasis: New opportunities to tackle therapeutic resistance
Seoane, J., & Mattos‐Arruda, L. D. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.05.009 · Cited by 46
Hensler, M., Vančurová, I., Becht, É., Palata, O., Strnad, P., Tesařová, P., Čabiňaková, M., Švec, D., Kubista, M., Bartůňková, J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1102827 · Cited by 41
Larionova, I., Zavyalova, M. V., Телегина, Н. С., Buldakov, M. A., Riabov, V., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.08.001 · Cited by 41
Stem-like features of cancer cells on their way to metastasis
Gkountela, S., & Aceto, N. (2016) · Biology Direct · doi:10.1186/s13062-016-0135-4 · Cited by 44
Xu, H., Dong, B., Xiao, Q., Sun, X., Zhang, X., Lyu, J., Yang, Y., Xu, L. H., Bai, X., Zhang, S., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10094 · Cited by 41
Arzi, L., Riazi, G. H., Sadeghizadeh, M., Hoshyar, R., & Jafarzadeh, N. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4248 · Cited by 47
“However, the majority of deaths from breast cancer is not due to the primary tumor itself, but is the result of metastasis to other organs, such as the lungs, liver, brain, and bones (Weigelt et al. , 2005).”
The Prospect and Challenges to the Flow of Liquid Biopsy in Africa
Temilola, D. O., Wium, M., Coulidiati, T. H., Adeola, H. A., Carbone, G. M., Catapano, C. V., & Zerbini, L. F. (2019) · Cells · doi:10.3390/cells8080862 · Cited by 42
Scimeca, M., Trivigno, D., Bonfiglio, R., Ciuffa, S., Urbano, N., Schillaci, O., & Bonanno, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.004 · Cited by 46
The effect of environmental Bisphenol A exposure on breast cancer associated with obesity
Engin, A. B., & Engin, A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103544 · Cited by 43
Kontoghiorghes, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213990 · Cited by 45
“However, this process is very difficult, especially at the later stages of cancer and mostly at the stage of metastasis, which is the leading cause of cancer-related deaths worldwide [5,6].”
InfluentialCheng, S., Tada, M., Hida, Y., Asano, T., Kuramae, T., 竹本, 法., Hamada, J., Miyamoto, M., Hirano, S., Kondo, S., et al. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.05.032 · Cited by 41
Park, S. Y., Kim, Y. H., KIM, Y., & Lee, S.-J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1518 · Cited by 49
Joossens, J., der Veken, P. V., Surpateanu, G. G., Lambeir, A., Sayed, I. E. T. E., Ali, O. M., Augustyns, K., & Haemers, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060622g · Cited by 41
Smeets, A., Daemen, A., Bempt, I. V., Gevaert, O., Claes, B., Wildiers, H. P. M. W., Drijkoningen, R., Hummelen, P. V., Lambrechts, D., Moor, B. D., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1265-5 · Cited by 41
“However, 20–30% of node positive patients remain free of distant metastases whereas 20–30% of lymph node negative patients will develop metastasis [2].”
Sun, M., Bloom, A. B., & Zaman, M. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131814 · Cited by 42
Expression of NgBR Is Highly Associated with Estrogen Receptor Alpha and Survivin in Breast Cancer
Wang, B., Zhao, B., North, P. E., Kong, A. L., Huang, J., & Miao, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078083 · Cited by 40
Geng, Y., Gao, Y., Ju, H., & Yan, F. (2012) · Cancer Science · doi:10.1111/cas.12052 · Cited by 40
Crivianu-Gaita, V., Aamer, M., Posaratnanathan, R. T., Romaschin, A. D., & Thompson, M. E. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.11.031 · Cited by 40
Trivanović, D. I., Jauković, A., Krstić, J., Nikolić, S., Djordjević, I. O., Кукољ, Т., Obradović, H., Mojsilović, S. B., Ilić, V. L., Santibanez, J. F., et al. (2016) · IUBMB Life · doi:10.1002/iub.1473 · Cited by 43
“Therefore, high protein level of uPA is considered as prognostic marker associated with high metastasis risk (10,17,22).”
BackgroundEvolutionary Ecology of Organs: A Missing Link in Cancer Development?
Thomas, F., Nesse, R. M., Gatenby, R. A., Gidoin, C., Renaud, F., Roche, B., & Újvári, B. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.06.009 · Cited by 43
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
Cai, Y., Nogales‐Cadenas, R., Zhang, Q., Lin, J.-R., Zhang, W., O’Brien, K., Montagna, C., & Zhang, Z. D. (2017) · BMC Genomics · doi:10.1186/s12864-017-3563-3 · Cited by 43
Sun, H., Yang, X., Zhao, Y., Tian, Q., Chen, M., Zhao, Y., & Jin, W. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.018 · Cited by 40
Sawicki, L. A., Ovadia, E. M., Pradhan, L., Cowart, J. E., ROSS, K. E., Wu, C. H., & Kloxin, A. M. (2019) · APL Bioengineering · doi:10.1063/1.5064596 · Cited by 45
The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment
Futakuchi, M., Lami, K., Tachibana, Y., Yamamoto, Y., Furukawa, M., & Fukuoka, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205117 · Cited by 45
Butler, C., Sprowls, S. A., Szalai, G., Arsiwala, T. A., Saralkar, P. A., Straight, B., Hatcher, A. S., Tyree, E., Yost, M., Köhler, W., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100775 · Cited by 40
Song, J., Eum, D., Park, S.-Y., Jin, Y., Shim, J.-W., Park, S.-J., Kim, M., Park, S.-J., Heo, K., & Choi, Y.-J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240533 · Cited by 44
Zhang, L., Fan, M., Napolitano, F., Gao, X., Xu, Y., & Li, L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02696-z · Cited by 51
Yu, R., Longo, J., van Leeuwen, J. E., Zhang, C., Branchard, E., Elbaz, M., Cescon, D. W., Drake, R. R., Dennis, J. W., & Penn, L. Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2642 · Cited by 42
Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone
Liu, S., Wu, D., Sun, X., Fan, Y., Zha, R., Jalali, A., Feng, Y., Li, K., Sano, T., Vike, N. L., et al. (2021) · Bone Research · doi:10.1038/s41413-021-00152-2 · Cited by 42
Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology
Xie, H., Appelt, J. W., & Jenkins, R. W. (2021) · Cancers · doi:10.3390/cancers13236052 · Cited by 42
Multimodality Imaging of IL-18–Binding Protein-Fc Therapy of Experimental Lung Metastasis
Cao, Q., Cai, W., Niu, G., He, L., & Chen, X. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0049 · Cited by 40
The inference of breast cancer metastasis through gene regulatory networks
Ahmad, F. K., Deris, S., & Othman, N. H. (2011) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.11.015 · Cited by 47
Finicelli, M., Benedetti, G., Squillaro, T., Pistilli, B., Marcellusi, A., Mariani, P., Santinelli, A., Latini, L., Galderisi, U., & Giordano, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1936 · Cited by 40
Srivastava, A., Fuchs, B., Zhang, K., Ruan, M. M., Halder, C., Mahlum, E., Weber, K. L., Bolander, M. E., & Sarkar, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2307 · Cited by 40
FERAL: network-based classifier with application to breast cancer outcome prediction
Allahyar, A., & de Ridder, J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv255 · Cited by 40
“The main cause of death in these patients is, however, not the primary tumor, but its metastases at distant sites (e.g. in bone, lung, liver and brain) (Weigelt et al. , 2005).”
BackgroundZheng, L., Zhang, Y., Zhan, Y.-Z., & Liu, C.-X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1105 · Cited by 39
Zheng, M., Zhou, Y., Yang, X., Tang, J., Wei, D., Zhang, Y., Jiang, J.-L., Chen, Z., & Zhu, P. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3172-7 · Cited by 39
Ai, M., Liang, K., Lü, Y., Qiu, S., & Fan, Z. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23295 · Cited by 39
Hallett, M. A., Teng, B., Hasegawa, H., Schwab, L. P., Seagroves, T. N., & Pourmotabbed, T. (2013) · Breast Cancer Research · doi:10.1186/bcr3385 · Cited by 39
Murray, L., Cooper, J. A., Hughes, C. M., Powe, D. G., & Cardwell, C. R. (2014) · Breast Cancer Research · doi:10.1186/bcr3638 · Cited by 39
Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes
Golubnitschaja, O., & Sridhar, K. C. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9816-8 · Cited by 40
Dutta, S., Lopez‐Charcas, O., Tanner, S., Gradek, F., Driffort, V., Roger, S., Selander, K. S., Velu, S. E., & Brouillette, W. J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.003 · Cited by 39
“The crude product was purified by column chromatography over Si gel, using MeOH/NH3 saturated CH2Cl2 (3:97) to afford 4(4-fluorophenyl)-N-(3-(piperdin-1-yl)propyl)butan-1-amine (4) (0.”
MethodA Hybrid Multiscale Model for Cancer Invasion of the Extracellular Matrix
Sfakianakis, N., Madzvamuse, A., & Chaplain, M. A. J. (2020) · Multiscale Modeling and Simulation · doi:10.1137/18m1189026 · Cited by 39
“Any encounter with blood or lymphatic vessels in the microenvironment initiates the spread of the cancer to secondary locations in the host i.e. metastasis, which accounts for over 90% of deaths due to cancer, [34, 53].”
BackgroundDickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases
Kasoha, M., Bohle, R. M., Seibold, A. M., Gerlinger, C., Juhasz‐Böss, I., & Solomayer, E. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9937-3 · Cited by 47
Huang, L., Jian, Z., Gao, Y., Zhou, P., Zhang, G., Jiang, B., & Lv, Y. (2019) · Aging · doi:10.18632/aging.102167 · Cited by 40
RetractedXing, M., Li, P., Wang, X., Li, J., Shi, J., Qin, J., Zhang, X., Ma, Y., Francia, G., & Zhang, J.-Y. (2019) · Cancers · doi:10.3390/cancers12010007 · Cited by 39
Bi, X., Lou, P., Song, Y., Sheng, X., Liu, R., Deng, M., Xu, Y., Li, G., Yuan, S., Zhang, H., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01873-8 · Cited by 39
Overview of the Biological Activity of Anthraquinons and Flavanoids of the Plant Rumex Species
Berillo, D. A., Kozhakhmetova, M., & Lebedeva, L. (2022) · Molecules · doi:10.3390/molecules27041204 · Cited by 44
State of Cell Unjamming Correlates with Distant Metastasis in Cancer Patients
Gottheil, P., Lippoldt, J., Grosser, S., Renner, F., Saibah, M., Tschodu, D., Poßögel, A.-K., Wegscheider, A.-S., Ulm, B., Friedrichs, K., et al. (2023) · Physical Review X · doi:10.1103/physrevx.13.031003 · Cited by 49
Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells
Xu, Y., Benlimame, N., Su, J., He, Q., & Alaoui‐Jamali, M. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604901 · Cited by 39
Fu, X., Giretti, M. S., Goglia, L., Flamini, M. I., Sanchez, A. M., Baldacci, C., Garibaldi, S., Sitruk-Ware, R. L., Genazzani, A. R., & Simoncini, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-166 · Cited by 39
Marimuthu, M., & Kim, S. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.02.027 · Cited by 40
Miura, D., Kida, Y., & Nojima, H. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.080 · Cited by 39
Engin, H. B., Guney, E., Keskin, O., Oliva, B., & Gursoy, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081035 · Cited by 39
Bellance, C., Khan, J. A., Méduri, G., Guiochon‐Mantel, A., Lombès, M., & Loosfelt, H. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-11-0807 · Cited by 39
Unahabhokha, T., Pithi Chanvorachote, B., & Pongrakhananon, V. (2016) · Tumor Biology · doi:10.1007/s13277-015-4717-z · Cited by 40
“Metastasis of cancer cell from the primary site to the distant secondary tumor is accused for more than 90 % of cancer patient death [26, 27].”
Parmar, M. B., Sundaram, D. N. M., Remant Bahadur, K. C., Maranchuk, R. A., Aliabadi, H. M., Hugh, J. C., Löbenberg, R., & Uludağ, H. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.036 · Cited by 39
A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells
Croucher, D. R., Saunders, D. N., Stillfried, G. E., & Ranson, M. (2007) · Biochemical Journal · doi:10.1042/bj20070767 · Cited by 47
Zhou, Y., Chu, P., Wang, Y., Li, N., Gao, Q., Wang, S., Wei, J., Xue, G., Zhao, Y., Jia, H., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1533 · Cited by 40
“While patients with early-stage, nonmetastatic disease often experience positive outcomes, the mortality rate for those with metastatic disease to distant organs remains high ( 1 ).”
Qin, J., Tang, J., Jiao, L., Ji, J., Chen, W.-D., Feng, G., Gao, Y.-H., Zhu, X., & Deng, R. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.002 · Cited by 40
Tang, Y., Zhu, L., Li, Y., Ji, J. F., Li, J., Yuan, F., Wang, D., Chen, W., Huang, O., Chen, X., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s1-s4 · Cited by 38
Cancer stem cell subsets and their relationships
Liu, H., Chen, C., Yang, H., Pan, Y., & Zhang, X. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-50 · Cited by 41
“Metastasis is a very important feature of malignant tumors, accounting for 90% death of tumor patients [90].”
BackgroundUnderstanding tumor heterogeneity as functional compartments - superorganisms revisited
Grünewald, T. G. P., Herbst, S. M., Heınze, J., & Burdach, S. E. G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-79 · Cited by 38
Imanishi, Y., Hu, B., Xiao, G., Yao, X., & Cheng, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235689 · Cited by 41
Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues
de Vega, R. G., Fernández‐Sánchez, M. L., Eiró, N., Vizoso, F. J., Sperling, M., Kärst, U., & Medel, A. S. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0537-x · Cited by 40
“Clinical parameters, such as the size of the primary tumor, the histological grade, classification, and regional lymph node involvement, are generally useful for prognosis [1].”
Kiso, M., Tanaka, S., Saji, S., Toi, M., & Sato, F. (2018) · International Journal of Cancer · doi:10.1002/ijc.31645 · Cited by 41
Shukla, S., Jandzinski, M., Wang, C., Gong, X., Bonk, K. W., Keri, R. A., & Steinmetz, N. F. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800139 · Cited by 40
Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
Graminha, A. E., Honorato, J., Luna-Dulcey, L., Godoy, L. R., Barbosa, M. F., Cominetti, M. R., Menezes, A. C. S., & Batista, A. A. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111021 · Cited by 38
Bai, X., Song, B., Chen, Z., Zhang, W., Chen, D., Dai, Y., Liang, S., Zhang, D., Zhao, Z., & Feng, L. P. (2021) · Lab on a Chip · doi:10.1039/d1lc00165e · Cited by 39
Zheng, H., Yuan, C., Cai, J., Pu, W., Wu, P. S., Li, C., Li, G., Zhang, Y., Zhang, J., Guo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01346-4 · Cited by 40
Qiu, L., Kang, D., Wang, C., Guo, W., Fu, F., Wu, Q., Xi, G., He, J., Zheng, L., Zhang, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31771-w · Cited by 39
“The risk of a disease, e.g., recurrence of cancer, is routinely assessed by prognostic biomarkers 2 .”
BackgroundApplication of three-dimensional (3D) bioprinting in anti-cancer therapy
Wu, B., Wu, Z. Q., Hou, Y.-Y., Fang, Z.-X., Deng, Y., Wu, H.-T., & Liu, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20475 · Cited by 44
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
Sjöström, M., Ossola, R., Breslin, T., Rinner, O., Malmström, L., Schmidt, A., Aebersold, R. H., Malmström, J. A., & Niméus, E. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00315 · Cited by 39
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade
Cashman, R., Cohen, H., Ben‐Hamo, R., Zilberberg, A., & Efroni, S. (2014) · Oncotarget · doi:10.18632/oncotarget.1783 · Cited by 38
“As it is not possible to accurately predict the risk of metastasis development in individual patients, many women who would be treated by local treatment alone, which includes surgery and radiotherapy, will needlessly be ‘over-treated’ and suffer the toxic side effects of chemotherapy [2].”
InfluentialFry, S. A., Sinclair, J., Timms, J. F., Leathem, A. J., & Dwek, M. V. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.011 · Cited by 42
Gehrau, R. C., D’Astolfo, D. S., Dumur, C. I., Bocco, J. L., & Koritschoner, N. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008929 · Cited by 38
A microfluidic device for isolation and characterization of transendothelial migrating cancer cells
Cui, X., Guo, W., Sun, Y., Sun, B., Hu, S., Sun, D., & Lam, R. H. W. (2017) · Biomicrofluidics · doi:10.1063/1.4974012 · Cited by 37
Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells
Kim, E., Kang, G.-J., Kang, J.-I., Boo, H., Hyun, J. W., Koh, Y. S., Chang, W.-Y., Kim, Y. R., Kwon, J.-M., Maeng, Y. H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24952 · Cited by 38
Li, W., Shao, B., Liu, C., Wang, H., Zheng, W., Kong, W., Liu, X., Xu, G., Wang, C., Li, H., et al. (2018) · Small Methods · doi:10.1002/smtd.201800122 · Cited by 40
Malekian, S., Rahmati, M., Sari, S., Kazemimanesh, M., Kheirbakhsh, R., Muhammadnejad, A., & Amanpour, S. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.039 · Cited by 39
DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation
Liu, J., Li, H., Mao, A., Lu, J., Liu, W., Qie, J., & Pan, G. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1859196 · Cited by 40
Zañudo, J. G. T., Mao, P., Alcon, C., Kowalski, K. J., Johnson, G. N., Xu, G., Baselga, J. M., Scaltriti, M., Letai, A. G., Montero, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1208 · Cited by 39
Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer
Ionkina, A. A., Balderrama-Gutierrez, G., Ibanez, K. J., Phan, S. H. D., Cortez, A. N., Mortazavi, A., & Prescher, J. A. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01468-x · Cited by 39
Chen, X., Feng, J., Chen, W., Shao, S., Chen, L., & Wan, H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00945-w · Cited by 39
Quintas, S. T., Canha‐Borges, A., Oliveira, M. J., Sarmento, B. F. C. C., & Castro, F. (2023) · Small · doi:10.1002/smll.202300666 · Cited by 43
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.